Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Masson

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
L'Encephale|December 6, 2024
[Eat well to live well: Is psychonutrition ready for clinical practice in mental health?]Guillaume Fond, Marc Masson
Bipolar Disorders|April 19, 2018
Bipolar disorder: a single illnessAroldo A Dargél, Marc Masson
L'Encephale|April 5, 2016
Turning certainties upside down: A homage to the work of Professor Robert L. SpitzerMarc Masson, Julien Cavanagh de Carvalho
The Australian and New Zealand Journal of Psychiatry|August 23, 2014
Lithium the magic ion: restoring and preventing?Marc Masson, Thomas Mauras, Gin S Malhi
The Australian and New Zealand Journal of Psychiatry|October 30, 2016
The RANZCP guidelines: Managing mood disorders in the real worldAroldo Ayub Dargél, Marc Masson, Chantal Henry
The Australian and New Zealand Journal of Psychiatry|September 30, 2015
Teasing apart Bipolar III: The causes and consequences of a Treatment-Emergent Affective Switch (TEAS) into maniaGin S Malhi, Marc Masson, Frank Bellivier
Drug Discovery Today|October 27, 2004
Quality: an old solution to new discovery dilemmas?Stephen G Volsen, Jackie M Kent, Marc Masson
L'Encephale|August 10, 2024
Pharmacological and nutraceutical treatments for borderline personality disorderCyril Gérolymos, Laurent Boyer, Marc Masson, et al.
The Journal of Clinical Psychiatry|June 24, 2016
Incentive Sensitivity as a Behavioral Marker of Clinical Remission From Major Depressive EpisodeThomas Mauras, Marc Masson, Philippe Fossati, et al.
L'Encephale|May 28, 2023
Cannabidiol (CBD) in psychiatric clinical practice: Current dataGuillaume Fond, Tiffanie Muller, Marc Masson, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
L'Encephale|December 6, 2024
[Eat well to live well: Is psychonutrition ready for clinical practice in mental health?]Guillaume Fond, Marc Masson
Bipolar Disorders|April 19, 2018
Bipolar disorder: a single illnessAroldo A Dargél, Marc Masson
L'Encephale|April 5, 2016
Turning certainties upside down: A homage to the work of Professor Robert L. SpitzerMarc Masson, Julien Cavanagh de Carvalho
The Australian and New Zealand Journal of Psychiatry|August 23, 2014
Lithium the magic ion: restoring and preventing?Marc Masson, Thomas Mauras, Gin S Malhi
The Australian and New Zealand Journal of Psychiatry|October 30, 2016
The RANZCP guidelines: Managing mood disorders in the real worldAroldo Ayub Dargél, Marc Masson, Chantal Henry
The Australian and New Zealand Journal of Psychiatry|September 30, 2015
Teasing apart Bipolar III: The causes and consequences of a Treatment-Emergent Affective Switch (TEAS) into maniaGin S Malhi, Marc Masson, Frank Bellivier
Drug Discovery Today|October 27, 2004
Quality: an old solution to new discovery dilemmas?Stephen G Volsen, Jackie M Kent, Marc Masson
L'Encephale|August 10, 2024
Pharmacological and nutraceutical treatments for borderline personality disorderCyril Gérolymos, Laurent Boyer, Marc Masson, et al.
The Journal of Clinical Psychiatry|June 24, 2016
Incentive Sensitivity as a Behavioral Marker of Clinical Remission From Major Depressive EpisodeThomas Mauras, Marc Masson, Philippe Fossati, et al.
L'Encephale|May 28, 2023
Cannabidiol (CBD) in psychiatric clinical practice: Current dataGuillaume Fond, Tiffanie Muller, Marc Masson, et al.
Pageof 2